Villacastín Julián, Bover Ramón, Castellano Nicasio P, Moreno Javier, Morales Ricardo, García-Espinosa Arturo
Unidad de Arritmias, Instituto Cardiovascular del Hospital Clínico San Carlos, Madrid, Spain.
Rev Esp Cardiol. 2004 Aug;57(8):768-82.
Patients with heart failure can die of progressive refractory heart failure or sudden cardiac death. This article reviews the major clinical predictors of sudden death in patients with heart failure due to left ventricular systolic dysfunction. Although earlier studies have identified many independent univariate predictors of reduced survival in these patients, the positive predictive value of most of them is low. Cardioverter defibrillator implantation has been shown to be the most effective therapy in patients resuscitated after cardiac arrest caused by ventricular fibrillation or poorly tolerated ventricular tachycardia. Low left ventricular ejection fraction, low New York Heart Association functional class, unsustained ventricular tachycardia and inducibility of ventricular arrhythmia in electrophysiological studies may also identify high-risk patients who are candidates for cardioverter defibrillator implantation. The role of amiodarone in preventing sudden death in high-risk patients with heart failure seems to be small. Further studies are needed to improve risk stratification criteria to select patients with heart failure who are candidates for cardioverter defibrillator implantation.
心力衰竭患者可能死于进行性难治性心力衰竭或心源性猝死。本文综述了左心室收缩功能障碍所致心力衰竭患者猝死的主要临床预测因素。尽管早期研究已确定了这些患者生存降低的许多独立单变量预测因素,但其中大多数的阳性预测价值较低。心脏复律除颤器植入已被证明是因室颤或耐受性差的室性心动过速导致心脏骤停后复苏患者最有效的治疗方法。左心室射血分数低、纽约心脏协会功能分级低、非持续性室性心动过速以及电生理研究中室性心律失常的可诱导性也可能识别出适合植入心脏复律除颤器的高危患者。胺碘酮在预防高危心力衰竭患者猝死方面的作用似乎较小。需要进一步研究以改进风险分层标准,从而选择适合植入心脏复律除颤器的心力衰竭患者。